Express News | Bristol Myers Squibb Co - Shareholder Proposal on Request to Cease Dei Efforts Not Approved at Annual Meeting - SEC Filing
Trump Planning on Executive Order to Further Cut Medicare Drug Prices - Report
Express News | 2seventy Bio Announces Bristol Myers Squibb Will Acquire All Remaining Shares Not Tendered In Offer Through Second-Step Merger At Same Price In Tender Offer Of $5.00/Share
2seventy Bio 1Q EPS 1c >TSVT
2seventy Bio: HSR Waiting Period Expired for Sale to Bristol Myers Squibb
Press Release: 2seventy Bio Reports First Quarter Financial Results and Provides Update on Proposed Acquisition by Bristol Myers Squibb
